Making Science Book Value Per Share vs. EBITDA

MAKS Stock  EUR 8.55  0.05  0.59%   
Based on the measurements of profitability obtained from Making Science's financial statements, Making Science Group may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Making Science's ability to earn profits and add value for shareholders.
For Making Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Making Science to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Making Science Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Making Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Making Science Group over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Making Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Making Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Making Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Making Science Group EBITDA vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Making Science's current stock value. Our valuation model uses many indicators to compare Making Science value to that of its competitors to determine the firm's financial worth.
Making Science Group is considered to be number one stock in book value per share category among its peers. It also is considered to be number one stock in ebitda category among its peers totaling about  1,307,317  of EBITDA per Book Value Per Share. Comparative valuation analysis is a catch-all model that can be used if you cannot value Making Science by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Making Science's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Making EBITDA vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Making Science

Book Value per Share

 = 

Common Equity

Average Shares

 = 
2.05 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Making Science

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
2.67 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Making EBITDA Comparison

Making Science is currently under evaluation in ebitda category among its peers.

Making Science Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Making Science, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Making Science will eventually generate negative long term returns. The profitability progress is the general direction of Making Science's change in net profit over the period of time. It can combine multiple indicators of Making Science, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Making Science Group, S.A. provides marketing and technology services in the areas of digital marketing, business analytics, electronic commerce, and cloud worldwide. The company was incorporated in 2001 and is based in Madrid, Spain. MAKING SCIENCE operates under Advertising Agencies classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 282 people.

Making Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Making Science. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Making Science position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Making Science's important profitability drivers and their relationship over time.

Use Making Science in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Making Science position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Making Science will appreciate offsetting losses from the drop in the long position's value.

Making Science Pair Trading

Making Science Group Pair Trading Analysis

The ability to find closely correlated positions to Making Science could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Making Science when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Making Science - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Making Science Group to buy it.
The correlation of Making Science is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Making Science moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Making Science Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Making Science can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Making Science position

In addition to having Making Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cash Cows Thematic Idea Now

Cash Cows
Cash Cows Theme
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Making Stock

To fully project Making Science's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Making Science Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Making Science's income statement, its balance sheet, and the statement of cash flows.
Potential Making Science investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Making Science investors may work on each financial statement separately, they are all related. The changes in Making Science's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Making Science's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.